These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 23187314)
1. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD. Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314 [TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study. Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304 [TBL] [Abstract][Full Text] [Related]
3. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease. Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402 [TBL] [Abstract][Full Text] [Related]
4. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records. Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations. Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632 [TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids do not influence the early inflammatory response and clinical presentation of hospitalized subjects with COPD exacerbation. Crisafulli E; Guerrero M; Menéndez R; Huerta A; Martinez R; Gimeno A; Soler N; Torres A Respir Care; 2014 Oct; 59(10):1550-9. PubMed ID: 25074943 [TBL] [Abstract][Full Text] [Related]
7. Effects of age and comorbidities on serum levels of inflammatory markers in community-acquired pneumonia. Viasus D; Simonetti AF; Estupiñan-Bohórquez AF; Carratalà J Eur J Clin Invest; 2021 Jun; 51(6):e13480. PubMed ID: 33350464 [TBL] [Abstract][Full Text] [Related]
8. Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics. Huerta A; Crisafulli E; Menéndez R; Martínez R; Soler N; Guerrero M; Montull B; Torres A Chest; 2013 Oct; 144(4):1134-1142. PubMed ID: 23828375 [TBL] [Abstract][Full Text] [Related]
9. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients. Lin SH; Ji BC; Shih YM; Chen CH; Chan PC; Chang YJ; Lin YC; Lin CH Int J Tuberc Lung Dis; 2013 Dec; 17(12):1638-44. PubMed ID: 24200282 [TBL] [Abstract][Full Text] [Related]
10. Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia. Singanayagam A; Chalmers JD; Akram AR; Hill AT Eur Respir J; 2011 Jul; 38(1):36-41. PubMed ID: 21429980 [TBL] [Abstract][Full Text] [Related]
11. IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients. Bacci MR; Leme RC; Zing NP; Murad N; Adami F; Hinnig PF; Feder D; Chagas AC; Fonseca FL Braz J Med Biol Res; 2015 May; 48(5):427-32. PubMed ID: 25714883 [TBL] [Abstract][Full Text] [Related]
12. Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia. Perren A; Cerutti B; Lepori M; Senn V; Capelli B; Duchini F; Domenighetti G Infection; 2008 Mar; 36(2):163-6. PubMed ID: 18330505 [TBL] [Abstract][Full Text] [Related]
14. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia. Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia. Ramírez P; Ferrer M; Martí V; Reyes S; Martínez R; Menéndez R; Ewig S; Torres A Crit Care Med; 2011 Oct; 39(10):2211-7. PubMed ID: 21705887 [TBL] [Abstract][Full Text] [Related]
16. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis. Hedlund J Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866 [TBL] [Abstract][Full Text] [Related]
18. Inhaled corticosteroids in COPD and the risk of pneumonia. Welte T Lancet; 2009 Aug; 374(9691):668-70. PubMed ID: 19716946 [No Abstract] [Full Text] [Related]
19. The natural history of community-acquired pneumonia in COPD patients: a population database analysis. Müllerova H; Chigbo C; Hagan GW; Woodhead MA; Miravitlles M; Davis KJ; Wedzicha JA Respir Med; 2012 Aug; 106(8):1124-33. PubMed ID: 22621820 [TBL] [Abstract][Full Text] [Related]
20. Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis. Loke YK; Kwok CS; Wong JM; Sankaran P; Myint PK Int J Clin Pract; 2013 May; 67(5):477-87. PubMed ID: 23574107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]